Biogen BIIB
NASDAQ BIIB
$219.88 -2.94 (-1.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biogen (BIIB) Consolidated Net Income (2009 - 2026)

Updated

Biogen (BIIB) posted Consolidated Net Income of $97.5 million for Q2 2026, down 84.6% from $634.8 million a year earlier and down 69.5% from the prior quarter.

Analysis

Biogen (BIIB) Consolidated Net Income (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at Biogen was $834.6 million, down 45.5% year-over-year; for FY2025, it was $1.29 billion, down 20.8% from FY2024.

  • Annual Consolidated Net Income shows a five-year compound annual growth rate of -20.5% (FY2020 to FY2025).
  • In prior years, Biogen's Consolidated Net Income was $1.63 billion in FY2024 (+40.5%), $1.16 billion in FY2023 (-60.8%), $2.96 billion in FY2022 (+71.4%) and $1.73 billion in FY2021 (-57.5%).
  • Quarterly Consolidated Net Income has run from a low of -$68.3 million in Q3 2023 to a high of $1.13 billion in Q3 2022 over five years.
  • On a year-over-year basis, Consolidated Net Income increased in four of the last six quarters, with an average decline of 9.1%.
  • The strongest year-over-year quarter for Consolidated Net Income in the past five years was Q3 2022, with growth of 256.8%; the weakest was Q2 2026, with a decline of 84.6%.
  • According to Business Quant data, Consolidated Net Income for the three prior quarters was $319.5 million (Q1 2026), -$48.9 million (Q4 2025) and $466.5 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 5.53 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.62 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.51 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.50 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -237.00 Mn
10 Biogen 32.49 Bn 19.14 Bn 1.96 Bn 97.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 97.50 Mn
Mar 31, 2026 319.50 Mn
Dec 31, 2025 -48.90 Mn
Sep 30, 2025 466.50 Mn
Jun 30, 2025 634.80 Mn
Mar 31, 2025 240.50 Mn
Dec 31, 2024 266.70 Mn
Sep 30, 2024 388.50 Mn
Jun 30, 2024 583.60 Mn
Mar 31, 2024 393.40 Mn
Dec 31, 2023 248.90 Mn
Sep 30, 2023 -68.30 Mn
Jun 30, 2023 593.30 Mn
Mar 31, 2023 387.60 Mn
Dec 31, 2022 549.50 Mn
Sep 30, 2022 1.13 Bn
Jun 30, 2022 1.06 Bn
Mar 31, 2022 218.50 Mn
Dec 31, 2021 -20.50 Mn
Sep 30, 2021 318.10 Mn
API Access

Biogen Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=BIIB&period=max&api_key=YOUR_API_KEY